Viewing data from:

BRINZOLAMIDE

ANDA

BRINZOLAMIDE | A211914 | PADAGIS US LLC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 2 NDCs

Highest NADAC/Unit

$10.08

per ml

Lowest NADAC/Unit

$9.49

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00574401215BRINZOLAMIDE 1% EYE DROPS	$10.08	ML	Generic	—	2026-08-19
00574401210BRINZOLAMIDE 1% EYE DROPS	$9.49	ML	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain13 active DMFs3 inactive

10 active API suppliers hold Drug Master Files for this ingredient.

ICROM SRLBRINZOLAMIDE (MICRONIZED, MICRONIZED AND STERILE)

DMF 254782011

NEULAND LABORATORIES LTDBRINZOLAMIDE, USP

DMF 258172012

INDUSTRIALE CHIMICA SRLBRINZOLAMIDE, USP

DMF 259182012

NEULAND LABORATORIES LTDBRINZOLAMIDE USP (STERILE)

DMF 269362013

INDOCO REMEDIES LTDBRINZOLAMIDE USP

DMF 281342014

BIOCON LTDBRINZOLAMIDE USP (STERILIZED)

DMF 289332015

SCI PHARMTECH INCBRINZOLAMIDE

DMF 297462015

DUKE CHEM SABRINZOLAMIDE MICRONIZED USP

DMF 322022018

PHARMATHEN SABRINZOLAMIDE

DMF 341672019

NEULAND LABORATORIES LTDBRINZOLAMIDE USP (PROCESS-II)

DMF 364522023

FDC LTDBRINZOLAMIDE USP

DMF 395122024

NEULAND LABORATORIES LTDBRINZOLAMIDE (PROCESS-II, STERILE)

DMF 399202024

MICRO LABS LTDBRINZOLAMIDE USP

DMF 405662024

VIWIT PHARMACEUTICAL CO LTDInactiveBRINZOLAMIDE USP

DMF 228512009

ALP PHARM BEIJING CO LTDInactiveBRINZOLAMIDE USP (DRUG SUBSTANCE, NON-STERILE)

DMF 237892010

BACHEM SAInactiveBRINZOLAMIDE

DMF 253242011

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 1%

0 patents0 exclusivities▴

SUSPENSION/DROPS;OPHTHALMIC | Approved: Jul 28, 2023

No patent or exclusivity listings for this strength.